Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 510, 520, 522, 524, 526, and 558
 AGENCY: Food and Drug Administration
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the change of sponsor for 25 approved new animal drug applications (NADA's) from Merial Ltd. to Bimeda, Inc.
 DATES: This rule is effective March 9, 2001.
 FOR FURTHER INFORMATION CONTACT: Norman J. Turner, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0214.


SUPPLEMENTARY INFORMATION: Merial Ltd., 2100 Ronson Rd., Iselin, NJ 08830-3077, has informed FDA that it has transferred ownership of, and all rights and interests in, the following approved NADA's to Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322. Accordingly, the agency is amending the regulations in 21 CFR parts 510, 520, 522, 524, 526, and 558 to reflect the change of sponsor. The agency is also amending § 510.60(c)(1) and (c)(2) to add the sponsor name and drug labeler code for Bimeda, Inc. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 510 Administrative practice and procedure
Animal drugs
Labeling
Reporting and recordkeeping requirements
 21 CFR Parts 520, 522, 524, and 526 Animal drugs. 21 CFR Part 558 Animal drugs, Animal feeds. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, 526, and 558 are amended as follows: PART 510—NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority:
                        21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding an entry for “Bimeda, Inc.” and in the table in paragraph (c)(2) by numerically adding an entry for “061133” to read as follows: § 510.600
  
 (c) * * * (1) * * * Firm name and address
Drug labeler code*          *          *          *          *          *          *Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322
061133*          *          *          *          *          *          *
 (2) * * * Drug labeler code
Firm name and address*          *          *          *          *          *          *061133
Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322*          *          *          *          *          *          *
 PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS 3. The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 520.390a
  4. Section 520.390a 
                            *Chloramphenicol tablets*
                             is amended in paragraph (b)(2) by removing “050604” and by adding in its place “061133”.
 § 520.540b
  5. Section 520.540b 
                            *Dexamethasone tablets and boluses*
                             is amended in paragraph (b)(2) by removing “050604” and by adding in its place “061133”.
 § 520.622a
  6. Section 520.622a 
                            *Diethylcarbamazine citrate tablets*
                             is amended in paragraph (a)(3) by removing “050604” and by adding in its place “061133”.
 § 520.622c
  7. Section 520.622c 
                            *Diethylcarbamazine citrate chewable tablets*
                             is amended in paragraph (b)(4) by removing “050604” and by adding in its place “061133”.
 § 520.823
  8. Section 522.823 
                            *Erythromycin phosphate*
                             is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.
 § 520.1484
  9. Section 520.1484 
                            *Neomycin sulfate soluble powder*
                             is amended in paragraph (b) by removing “050604, and” and by adding “, and 061133” after “051259”.
 § 520.1660d
  10. Section 520.1660d 
                            *Oxytetracycline hydrochloride soluble powder*
                             is amended in paragraph (b)(7) by removing “050604” and by adding in its place “061133”.
 § 520.1696b
  11. Section 520.1696b 
                            *Penicillin G potassium in drinking water*
                             is amended in paragraph (b) by removing “050604, and” and by adding “, and 061133” after “053501”.
 § 520.1720a
  12. Section 520.1720a 
                            *Phenylbutazone tablets and boluses*
                             is amended in paragraph (b)(3) by removing “and 059130” and by adding in its place “059130, and 061133”.
 § 520.1720d
  13. Section 520.1720d 
                            *Phenylbutazone gel*
                             is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.
 § 520.2123a
  14. Section 520.2123a 
                            *Spectinomycin dihydrochloride pentahydrate tablets*
                             is amended in paragraph (b), by removing “050604” and by adding in its place “061133”.
 § 520.2123b
  15. Section 520.2123b 
                            *Spectinomycin dihydrochloride pentahydrate soluble powder*
                             is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.
 § 520.2260b
  16. Section 520.2260b 
                            *Sulfamethazine sustained-release boluses*
                             is amended in paragraphs (c)(1) and (e)(1) by removing “050604” and by adding in its place “061133”.
 PART 522—IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS 17. The authority citation for 21 CFR part 522 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 522.820
  18. Section 522.820 
                            *Erythromycin injection*
                             is amended in paragraph (a) by removing “050604” and by adding its place “061133”.
 § 522.2444b
  19. Section 522.2444b 
                            *Sodium thiopental, sodium pentobarbital for injection*
                             is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.
 PART 524—OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS 20. The authority citation for 21 CFR part 524 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 524.1580b
  21. Section 524.1580b 
                            *Nitrofurazone ointment*
                             is amended in paragraph (b) by removing “and 051259” and by adding in its place “051259, and 061133”.
 PART 526—INTRAMAMMARY DOSAGE FORMS 22. The authority citation for 21 CFR part 526 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 526.820
  23. Section 526.820 
                            *Erythromycin*
                             is amended in paragraph (b) by removing “050604” and by adding in its place “061133”.
 PART 558—NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS 24. The authority citation for 21 CFR part 558 continues to read as follows: Authority:
                        21 U.S.C. 360b, 371. § 558.58
  25. Section 558.58 
                            *Amprolium and ethopabate*
                             is amended in the table in paragraph (d)(1), in item (iii), for the entry “Arsanilic acid 90 (0.01 pct) plus erythromycin 4.6 to 18.5”, under the “Sponsor” column by adding “061133”. 26. Section 558.62 is amended by revising paragraph (a)(1), by adding paragraph (a)(3), and in the table in paragraph (c)(1) by redesignating entries (c)(1)(iii), (c)(1)(iv), and (c)(1)(v) as entries (c)(1)(iv), (c)(1)(vi), and (c)(1)(vii), respectively, and by adding new entries (c)(1)(iii) and (c)(1)(v) to read as follows:
 § 558.62
  (a) * * * (1) To 015565: 20, 50, and 100 percent for use as in the table in paragraph (c)(1), entry (ii), item 1; entry (ii), item 2; entry (iv); entry (vi); and entry (vii) of this section. *  *  *  *  * (3) To 061133: 90 grams per pound arsanilic acid and 4.6 grams per pound erythromycin equivalents as erythromycin thiocyanate for use as in paragraph (c)(1), entry (iii); 90 grams per pound arsanilic acid and 9.25 grams per pound erythromycin equivalents as erythromycin thiocyanate for use as in paragraph (c)(1), entry (v). *  *  *  *  * (c) * * * (1) * * * Arsanilic acid in grams per ton
Combination in grams per ton
Indications for use
Limitations
Sponsor*          *          *          *          *          *          *(iii)
Erythromycin 4.6
Chickens; growth promotion and feed efficiency; improving pigmentation.
As erythromycin thiocyanate; withdraw 5 days before slaughter; as sole source of organic arsenic.
012487*          *          *          *          *          *          *(v)
Erythromycin 9.25
Chickens; growth promotion and feed efficiency; improving pigmentation.
As erythromycin thiocyanate; withdraw 5 days before slaughter; as sole source of organic arsenic.
012487*          *          *          *          *          *          *
 *  *  *  *  *
 § 558.248
  27. Section 558.248 
                            *Erythromycin thiocyanate*
                             is amended in paragraphs (a)(1) and (a)(2) by removing “050604” and by adding in its place “061133”, and in the table in paragraph (d)(1), in entries (i) through (vi), under the “Sponsor” column by removing “050604” wherever it appears and by adding in its place “061133”.
 § 558.625
  28. Section 558.625 
                            *Tylosin*
                             is amended in paragraph (b)(39) by removing “50604” and by adding in its place “061133”.
 Dated: January 29, 2001 Claire M. Lathers, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.


[FR Doc. 01-5680 Filed 3-8-01; 8:45 am] BILLING CODE 4160-01-F